Buspirone Hydrochloride Tablet
Product Images NDC 75834-270

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 16 technical images submitted to the FDA as part of the official labeling for Buspirone Hydrochloride (NDC 75834-270). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nivagen Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Buspirone 01)

FDA Label Image

Image (Buspirone 02)

FDA Label Image

Image (Buspirone 03)

FDA Label Image

Image (Buspirone 04)

FDA Label Image

Image (Buspirone 05)

FDA Label Image

Image (Buspirone 06)

FDA Label Image

Image (Buspirone 07)

FDA Label Image

Image (Buspirone 08)

FDA Label Image

Image (Buspirone 09)

FDA Label Image

Image (Buspirone 10)

FDA Label Image

Image (Buspirone 11)

FDA Label Image

Principal Display Panel (5 mg Tablet Bottle Label)

Principal Display Panel (5 mg Tablet Bottle Label)
This is a medication called Ach Abet with NDC number 75834-266-01 manufactured by InventiaHealthcars. It contains buspirone hydrochloride, USP and is stored in tablets USP. The package insert contains information on the recommended dosage, and the medication should be dispensed in a tight, light-resistant container, with a child-resistant closure. The manufacturing date is indicated as well as the expiration date. This medication is intended for human consumption.*
FDA Label Image

Principal Display Panel (7.5 mg Tablet Bottle Label)

Principal Display Panel (7.5 mg Tablet Bottle Label)
This is a description of a medication with the National Drug Code (NDC) 75834-267-01. The medication is in the form of tablets containing 7.5 mg of busPIRone Hydrochloride, USP. The package contains 100 tablets and should be stored in a place with a controlled USP room temperature of 20° to 25°C (68° to 77°F). The medication is manufactured by Inventia Healthcare Limited in India and distributed in the United States by Nivagen Pharmaceuticals, Inc. The prescription for the medication can be found in the package insert. The medication should be kept out of reach of children and dispensed in a light-resistant container with a child-resistant closure. The lot number is "RRERIRIRIK," and the manufacturing date is "3. K%." The expiration date is "14R.RRRR."*
FDA Label Image

Principal Display Panel (10 mg Tablet Bottle Label)

Principal Display Panel (10 mg Tablet Bottle Label)
Each tablet of this medication contains 10mg of buspirone hydrochloride, USP, manufactured by Inventia Healthcare Limited in India. The package insert contains usual dosage information and the medication is manufactured for Pramaceuticals in Sacramento, CA. This medication should be stored at controlled room temperature and kept out of the reach of children. The lot number is ATEO745L/01 and the expiration date is 10/12/2020.*
FDA Label Image

Principal Display Panel (15 mg Tablet Bottle Label)

Principal Display Panel (15 mg Tablet Bottle Label)
This is a medication package of BusPIRone Hydrochloride Tablets, USP manufactured by Inventia Healthcare Limited in India and distributed by Nivagen Pharmaceuticals, Inc. in Sacramento, CA, USA. The tablets are intended for human consumption and one package contains 100 tablets, each containing 15 mg of the active ingredient buspirone hydrochloride. The package insert contains the prescribing information, and it is recommended to store the tablets in a tight, light-resistant container. The medication should be kept out of the reach of children. The manufacturing license number is KD/638, and the revision date of the package is 10/2020.*
FDA Label Image

Principal Display Panel (30 mg Tablet Bottle Label)

Principal Display Panel (30 mg Tablet Bottle Label)
This is a description of a medication with the NDC number 75834-270-60. The medication is busPIRone Hydrochloride, in tablet form containing 30 mg of the active ingredient, and is manufactured by Inventia Healthcare Limited in India. The tablets come in a pack of 60, and there is a toll-free number for more information. The package includes a patient information leaflet, and the pharmacist is instructed to store the medication at 20-25°C in a tightly sealed, light-resistant container that is child-resistant. The dosage information can be found in the package insert, and the medication should be kept out of the reach of children. No information is available about the medication's uses or side effects.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.